i-Lumen Scientific™ is a retinal biotech company, pioneering a new field in ophthalmics, designed to improve eyesight in patients whose vision has been impaired by nonexudative (dry) age-related macular degeneration (dAMD). This new therapy has the potential to address a large unmet patient need in the practice of ophthalmology.

 

The i-LUMEN™ system and therapy, developed by i-Lumen Scientific, utilizes a revolutionary, non-invasive, software-based, medical device, to deliver proprietary pulsed microcurrent stimulation for the treatment of dry AMD.

 

Macular degeneration is a highly debilitating visual disease, with no cure, and no cleared or approved treatments in the U.S. market for the treatment of dAMD. Now, with i-Lumen™ technology, there is finally hope for those afflicted with dry AMD.